|
| |
CepheidCepheid develops, manufactures, and markets fully-integrated systems that perform genetic analysis, including DNA and RNA analysis, for the clinical genetic assessment, biothreat, and life sciences markets. Our systems enable rapid, sophisticated genetic testing of organisms by automating otherwise complex manual laboratory procedures.
Genetic testing involves a number of complicated steps, including sample preparation, amplification and detection. Based on state-of-the-art microfluidic and microelectronic technologies, our easy-to-use systems integrate these steps and analyze complex biological samples in our proprietary test cartridges. We are focusing our efforts on those applications where rapid genetic testing is particularly important, such as the infectious disease, cancer and biothreat testing markets.
Our SmartCycler® and GeneXpert® systems can perform a broad range of genetic tests that include identifying infectious organisms and evaluating at-risk populations for the early detection of disease. Physicians can also determine the stage of a disease, such as cancer, and assess what therapy might be most effective. We have also adapted our systems to enable the rapid detection and identification of organisms that may serve as biothreat agents.
| Contact Details: |
| 904 Caribbean Drive |
| Sunnyvale |
| California |
| 94089 |
| United States of America |
| Tel: | 1-408-541-4191 |
| Fax: | 1-408-541-4192 |
| Email: | tross@financialrelationsboard.com |
| WWW: | www.cepheid.com/
|
|
Loading...
|
Recent Publications by Cepheid: |  |
Rapid detection of Mycobacterium tuberculosis and rifampin-resistance using on-demand, near patient technology.
Current nucleic acid amplification methods to detect Mycobacterium... | 30th October, 2009
| Department of Medicine, New Jersey Medical School - UMDNJ, Newark, NJ;
| J Clin Microbiol. 2009 Oct 28.
DOI Direct Link |
Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology.
Methicillin-resistant Staphylococcus aureus (MRSA) PFGE strain type USA300... | 2nd October, 2009
| Cepheid,
| J Antimicrob Chemother. 2009 Sep;64(3):441-6. Epub 2009 Jul 16.
DOI Direct Link |
Analysis of varicella-zoster virus and herpes simplex virus in various clinical samples by the use of different PCR assays.
Rapid and reliable detection of varicella-zoster virus (VZV) and herpes... | 12th August, 2009
| Cepheid Europe, Maurens Scopont, France.
| J Virol Methods. 2009 Sep;160(1-2):193-6. Epub 2009 May 9.
DOI Direct Link |
Implementing a real-time PCR assay for rapid surveillance of MRSA.
Rapid and reliable detection of varicella-zoster virus (VZV) and herpes... | 28th April, 2009
| Cepheid, USA.
| MLO Med Lab Obs. 2009 Feb;41(2):18, 20-1.
|
Sputum, the final frontier: PCR from the research bench to the MRSA diagnostic trench.
Rapid and reliable detection of varicella-zoster virus (VZV) and herpes... | 7th January, 2009
| Cepheid, Sunnyvale, CA, USA.
| MLO Med Lab Obs. 2008 Nov;40(11):28, 30-1.
|
→View more Cepheid research publications. |
Press Releases on Cepheid:
|
 |
| Reportlinker Adds Automated and Rapid Microbiological Tests - A Worldwide Market Review |
18th November, 2009 |
Reportlinker |
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Automated and Rapid Microbiological Tests - A Worldwide Market Review
|
| Reportlinker Adds Molecular Diagnostics: A Dynamic and Rapidly Broadening Market |
29th October, 2009 |
Reportlinker |
-- Major trends in the molecular diagnostics market, such as the increasing
number of tests that are commercially available
Chapter 1
BACKGROUND AND SCOPE
1.1. Background
1.2. Focus
|
| Cepheid Reports 2009 Third Quarter Results |
28th October, 2009 |
Cepheid |
-- Total product sales of $40.8 million in the third quarter of 2009,
compared to $42.4 million in the third quarter of 2008. By industry,
product sales were, in millions:
|
| Gen-Probe Completes Acquisition of Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases |
22nd October, 2009 |
Gen-Probe Incorporated |
SAN DIEGO, Oct. 22 /PRNewswire-FirstCall/ -- Gen-Probe (Nasdaq: GPRO) announced today that the Company has completed its acquisition of Prodesse, Inc., a leader in molecular testing for influenza and
|
| Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations |
13th October, 2009 |
Cepheid |
SUNNYVALE, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that it has appointed Mr. Nicolaas ('Nico') Arnold to the position of Executive Vice President of
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 306 times since April 2007, the link to the organisation's website has been followed 32 times Recent Search Terms used to find this page: 6713297 cepheid | . Search for more companies in Sunnyvale Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Cepheid |
